New insights into the genetic etiology of Alzheimer's disease and related dementias

Characterization of the genetic landscape of Alzheimer's disease (AD) and related dementias (ADD) provides a unique opportunity for a better understanding of the associated pathophysiological processes. We performed a two-stage genome-wide association study totaling 111,326 clinically diagnosed/'proxy' AD cases and 677,663 controls. We found 75 risk loci, of which 42 were new at the time of analysis. Pathway enrichment analyses confirmed the involvement of amyloid/tau pathways and highlighted microglia implication. Gene prioritization in the new loci identified 31 genes that were suggestive of new genetically associated processes, including the tumor necrosis factor alpha pathway through the linear ubiquitin chain assembly complex. We also built a new genetic risk score associated with the risk of future AD/dementia or progression from mild cognitive impairment to AD/dementia. The improvement in prediction led to a 1.6- to 1.9-fold increase in AD risk from the lowest to the highest decile, in addition to effects of age and the APOE ε4 allele

A review of nuclear data needs and their status for fusion reactor technology with some suggestions on a strategy to satisfy the requirements

A review was performed on the needs and status of nuclear data for fusion-reactor technology. Generally, the status of nuclear data for fusion has been improved during the past two decades due to the dedicated effort of the nuclear data developers. However, there are still deficiencies in the nuclear data base, particularly in the areas of activation and neutron scattering cross sections. Activation cross sections were found to be unsatisfactory in 83 of the 153 reactions reviewed. The scattering cross sections for fluorine and boron will need to be improved at energies above 1 MeV. Suggestions concerning a strategy to address the specific fusion nuclear data needs for dosimetry and activation are also provided